Page last updated: 2024-11-02

moxonidine and Dementia

moxonidine has been researched along with Dementia in 1 studies

moxonidine: structure given in first source

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Martynov, AI1
Ostroumova, OD1
Korsakova, NK1
Sergienko, VB1
Varako, NA1
Bagramova, IuA1

Trials

1 trial available for moxonidine and Dementia

ArticleYear
[Influence of long-term moxonidine (psysiotens) monotherapy on neuropsychological status and brain perfusion in elderly patients with arterial hypertension].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2002, Volume: 102, Issue:3

    Topics: Aged; Antihypertensive Agents; Brain; Cognition; Dementia; Female; Frontal Lobe; Humans; Hypertensio

2002